Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators

Nature Medicine

Volumn 10, Issue 2, 2004, Pages 175-181

  Yu, Yanlin ^a   Khan, Javed ^a   Khanna, Chand ^a   Helman, Lee ^a   Meltzer, Paul S ^b   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARF PROTEIN; BIOLOGICAL FACTOR; EZRIN; HOMEODOMAIN PROTEIN; SCATTER FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SINE OCULIS RELATED HOMEOBOX 1; TRANSCRIPTION FACTOR VIL 2; UNCLASSIFIED DRUG; CYTOSKELETON PROTEIN; PHOSPHOPROTEIN; SIX1 PROTEIN, HUMAN; SIX1 PROTEIN, MOUSE;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CANCER TISSUE; CELL MEMBRANE; CONTROLLED STUDY; CYTOSKELETON; DERIVATIZATION; DNA MICROARRAY; GENE IDENTIFICATION; GENETIC CODE; HOMEOBOX; HUMAN; HUMAN CELL; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; RHABDOMYOSARCOMA; TRANSGENIC MOUSE; ANIMAL; C57BL MOUSE; CHILD; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHENOTYPE; PHYLOGENY; TUMOR CELL LINE;

ANIMALIA; MUS MUSCULUS;

ANIMALS; CELL LINE, TUMOR; CHILD; CYTOSKELETAL PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; PHOSPHOPROTEINS; PHYLOGENY; RHABDOMYOSARCOMA;

EID: 1442304609     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm966     Document Type: Article

References (45)

1. Merlino, G. & Helman, L.J. Rhabdomyosarcoma - working out the pathways. Oncogene 18, 5340-5348 (1999).
2. Dagher, R. & Helman, L. Rhabdomyosarcoma: an overview. Oncologist 4, 34-44 (1999).
3. Ruymann, F.B. & Grovas, A.C. Progress in the diagnosis and treatment of rhabdomyosarcoma and related soft tissue sarcomas. Cancer Invest. 18, 223-241 (2000).
4. Khanna, C. et al. Metastasis-associated differences in gene expression in a murine model of osteosarcoma. Cancer Res. 61, 3750-3759 (2001).
5. Ramaswamy, S., Ross, K.N., Lander, E.S. & Golub, T.R. A molecular signature of metastasis in primary solid tumors. Nat. Genet. 33, 49-54 (2003).
6. Ye, Q.H. et al. Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat. Med. 9, 416-423 (2003).
7. Sharp, R. et al. Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis. Nat. Med. 8, 1276-1280 (2002).
8. Khan, J. et al. cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene. Proc. Natl. Acad. Sci. USA 96, 13264-13269 (1999).
9. Bittner, M. et al. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature 406, 536-540 (2000).
10. Tran Quang, C., Gautreau, A., Arpin, M. & Treisman, R. Ezrin function is required for ROCK-mediated fibroblast transformation by the net and dbl oncogenes. EMBO J. 19, 4565-4576 (2000).
11. Ng, T. et al. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 20, 2723-2741 (2001).
12. Khanna, C. et al. Ezrin, a membrane-cytoskeleton linker, is necessary for osteosarcoma metastasis. Nat. Med. (in the press).
13. Maniotis, A.J. et al. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 155, 739-752 (1999).
14. Zhang, Y.W. & Vande Woude, G.F. HGF/SF-met signaling in the control of branching morphogenesis and invasion. J. Cell. Biochem. 88, 408-417 (2003).
15. Louvet-Vallee, S. ERM proteins: from cellular architecture to cell signaling. Biol. Cell 92, 305-316 (2000).
16. Bretscher, A., Edwards, K. & Fehon, R.G. ERM proteins and merlin: integrators at the cell cortex. Nat. Rev. Mol. Cell Biol. 3, 586-599 (2002).
17. Ford, H.L., Kabingu, E.N., Bump, E.A., Mutter, G.L. & Pardee, A.B. Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc. Natl. Acad. Sci. USA 95, 12608-12613 (1998).
18. Ford, H.L. et al. Cell cycle-regulated phosphorylation of the human SIX1 homeodomain protein. J. Biol. Chem. 275, 22245-22254 (2000).
19. Clark, E.A., Golub, T.R., Lander, E.S. & Hynes, R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature 406, 532-535 (2000).
20. Matsui, T. et al. Rho-kinase phosphorylates COOH-terminal threonines of ezrin/radixin/moesin (ERM) proteins and regulates their head-to-tail association. J. Cell Biol. 140, 647-657 (1998).
21. Krieg, J. & Hunter, T. Identification of the two major epidermal growth factor-induced tyrosine phosphorylation sites in the microvillar core protein ezrin. J. Biol. Chem. 267, 19258-19265 (1992).
22. Crepaldi, T., Gautreau, A., Comoglio, P.M., Louvard, D. & Arpin, M. Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells. J. Cell Biol. 138, 423-434 (1997).
23. Nestl, A., et al. Gene expression patterns associated with the metastatic phenotype in rodent and human tumors. Cancer Res. 61, 1569-1577 (2001).
24. Gautreau, A., Louvard, D. & Arpin, M. ERM proteins and NF2 tumor suppressor: the Yin and Yang of cortical actin organization and cell growth signaling. Curr. Opin. Cell Biol. 14, 104-109 (2002).
25. Etienne-Manneville, S. & Hall, A. Rho GTPases in cell biology. Nature 420, 629-635 (2002).
26. Sahai, E. & Marshall, C.J. RHO-GTPases and cancer. Nat. Rev. Cancer 2, 133-142 (2002).
27. Takahashi, K. et al. Direct interaction of the Rho GDP dissociation inhibitor with ezrin/radixin/moesin initiates the activation of the Rho small G protein. J. Biol. Chem. 272, 23371-23375 (1997).
28. Lamb, R.F. et al. The TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho. Nat. Cell Biol. 2, 281-287 (2000).
29. Ren, X.D., Kiosses, W.B. & Schwartz, M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18, 578-585 (1999).
30. Danen, E.H., Sonneveld, P., Sonnenberg, A. & Yamada, K.M. Dual stimulation of Ras/mitogen-activated protein kinase and RhoA by cell adhesion to fibronectin supports growth factor-stimulated cell cycle progression. J. Cell Biol. 151, 1413-1422 (2000).
31. Relaix, F. & Buckingham, M. From insect eye to vertebrate muscle: redeployment of a regulatory network. Genes Dev. 13, 3171-1318 (1999).
32. Heanue, T.A. et al. Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation. Genes Dev. 13, 3231-3243 (1999).
33. Kardon, G., Heanue, T.A. & Tabin, C.J. Pax3 and Dach2 positive regulation in the developing somite. Dev. Dyn. 224, 350-355 (2002).
34. Laclef, C. et al. Altered myogenesis in Six1-deficient mice. Development 130, 2239-2252 (2003).
35. Spitz, F. et al. Expression of myogenin during embryogenesis is controlled by Six/sine oculis homeoproteins through a conserved MEF3 binding site. Proc. Natl. Acad. Sci. USA 95, 14220-14225 (1998).
36. Schafer, K. & Braun, T. Early specification of limb muscle precursor cells by the homeobox gene Lbx1h. Nat Genet. 23, 213-216 (1999).
37. Brummelkamp, T.R., Bernards, R. & Agami, R. A system for stable expression of short interfering RNAs in mammalian cells. Science 296, 550-553 (2002).
38. Khan, J. et al. Expression profiling in cancer using cDNA microarrays. Electrophoresis 20, 223-229 (1999).
39. Chen, Y., Dougherty, E.R. & Bittner, M.L. Ratio-based decisions and the quantitative analysis of cDNA microarray images. Biomed. Optics 2, 364-374 (1997).
40. Chen, Y. et al. Ratio statistics of gene expression levels and applications to microarray data analysis. Bioinformatics 18, 1207-1215 (2002).
41. Ringner, M., Peterson, C. & Khan, J. Analyzing array data using supervised methods. Pharmacogenomics 3, 403-415 (2002).
42. Yu, Y. & Merlino, G. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model. Cancer Res. 62, 2951-2956 (2002).
43. Shao, R. et al. Inhibition of nuclear factor-κB activity is involved in E1A-mediated sensitization of radiation-induced apoptosis. J. Biol. Chem. 272, 32739-32742 (1997).
44. Pollack, A.L., Barth, A.I., Altschuler, Y., Nelson, W.J. & Mostov, K.E. Dynamics of β-catenin interactions with APC protein regulate epithelial tubulogenesis. J. Cell Biol. 137, 1651-1662 (1997).
45. Khanna, C. et al. An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18, 261-271 (2000).